Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ATG-1144
- Development stage
- Preclinical
- Lead developer
- Antengene
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous, Subcutaneous
01
Overview
ATG-1144 is a novel investigational agent that specifically binds to human CD24 with high sensitivity, as demonstrated by immunohistochemistry (IHC) staining. The development and validation of the detection method for this drug have been completed, suggesting its potential use as a diagnostic tool for identifying CD24-positive patients. While detailed clinical data are not yet available, the specificity for CD24 indicates possible applications in oncology or other diseases where CD24 expression is relevant. The drug is being developed by Antengene, a biopharmaceutical company focused on innovative therapeutics for hematologic malignancies and solid tumors[1][3].
- Brand names
- ATG-1144ATG1144ATG 1144
- Other names
- ATG-1144ATG1144ATG 1144
02
Targets
CD24 (Cluster of Differentiation 24)
Beyond the preview
Go deeper on ATG-1144.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ATG-1144.